-
1دورية أكاديمية
المؤلفون: Illés, Zsolt, Sejbaek, Tobias, Csépány, Tünde
المصدر: Illés , Z , Sejbaek , T & Csépány , T 2015 , ' Alemtuzumab : egy új terápia előnyei és kihívásai sclerosis multiplexben ' , Ideggyogyaszati Szemle , bind 68 , nr. 5-6 , s. 155-164 . https://doi.org/10.18071/isz.68.0155Test
مصطلحات موضوعية: Adjuvants, Immunologic, Adult, Antibodies, Monoclonal, Humanized, Brain, Clinical Trials as Topic, Disease Progression, Drug Administration Schedule, Europe, Female, Humans, Interferon beta-1a, Interferon-beta, Magnetic Resonance Imaging, Multiple Sclerosis, Relapsing-Remitting, Myelitis, Transverse, Spinal Cord, Treatment Outcome, Relapse, Secunder autoimmunity, UP, EDSS, Alemtuzumab, Interferon-j31 a
العلاقة: https://portal.findresearcher.sdu.dk/da/publications/37bffbae-147b-4575-aa49-22694ad4739aTest
الإتاحة: https://doi.org/10.18071/isz.68.0155Test
https://portal.findresearcher.sdu.dk/da/publications/37bffbae-147b-4575-aa49-22694ad4739aTest -
2
المؤلفون: Illés, Zsolt, Sejbaek, Tobias, Csépány, Tünde
المصدر: Illés, Z, Sejbaek, T & Csépány, T 2015, ' Alemtuzumab : egy új terápia előnyei és kihívásai sclerosis multiplexben ', Ideggyogyaszati Szemle, bind 68, nr. 5-6, s. 155-164 . https://doi.org/10.18071/isz.68.0155Test
مصطلحات موضوعية: Adult, Clinical Trials as Topic, UP, Multiple Sclerosis, Interferon-j31 a, Brain, Interferon-beta, Myelitis, Transverse, Antibodies, Monoclonal, Humanized, Magnetic Resonance Imaging, Drug Administration Schedule, Secunder autoimmunity, Europe, Multiple Sclerosis, Relapsing-Remitting, Treatment Outcome, Adjuvants, Immunologic, Spinal Cord, Disease Progression, Humans, Female, EDSS, Relapse, Alemtuzumab, Interferon beta-1a
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od______3062::1798dadd73ecfbdb0826fd7def3f299bTest
https://portal.findresearcher.sdu.dk/da/publications/37bffbae-147b-4575-aa49-22694ad4739aTest